Vesicular Stomatitis Virus peptide

Ref. 3D-PP43946

Informations sur le produit

• Nom: Vesicular Stomatitis Virus peptide
• Synonymes: H-RGYVYQGL-OH

Description

Peptide Vesicular Stomatitis Virus peptide is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Vesicular Stomatitis Virus peptide include the following: MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma TL Tinder, DB Subramani, GD Basu - The Journal of , 2008 - journals.aai.orghttps://journals.aai.org/jimmunol/article/181/5/3116/80692 CD2 facilitates differentiation of CD4 Th cells without affecting Th1/Th2 polarization T Sasada, H Yang, EL Reinherz - The Journal of Immunology, 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/168/3/1113/34639 Applications of major histocompatibility complex class I molecules expressed as single chains T Primeau, NB Myers, YY Lawrence Yu, L Lybarger - Immunologic , 2005 - Springerhttps://link.springer.com/article/10.1385/IR:32:1-3:109 Cutting Edge: Cross-Priming of CTL Responses In Vivo Does Not Require Antigenic Peptides in the Endoplasmic Reticulum of Immunizing Cells SP Schoenberger , EIH van der Voort - The Journal of , 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/161/8/3808/31694 MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model P Mukherjee , LB Pathangey, JB Bradley, TL Tinder - Vaccine, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X06012035 Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition P Mukherjee , GD Basu, TL Tinder - The journal of , 2009 - journals.aai.orghttps://journals.aai.org/jimmunol/article/182/1/216/78780 Empty and peptide-containing conformers of class I major histocompatibility complex molecules expressed in Drosophila melanogaster cells. MR Jackson, ES Song, Y Yang - Proceedings of the , 1992 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.89.24.12117 Murine cytomegalovirus interacts with major histocompatibility complex class I molecules to establish cellular infection MN Wykes , GR Shellam, J McCluskey , WM Kast - Journal of , 1993 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.67.7.4182-4189.1993 Degenerate recognition of alloantigenic peptides on a positive-selecting class I molecule MD Tallquist, AJ Weaver, LR Pease - The Journal of Immunology, 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/160/2/802/69204 IL-12 enhances CTL synapse formation and induces self-reactivity MA Markiewicz , EL Wise, ZS Buchwald - The Journal of , 2009 - journals.aai.orghttps://journals.aai.org/jimmunol/article/182/3/1351/83625 The good, the bad and the ugly: how altered peptide ligands modulate immunity M Katsara, G Minigo , M Plebanski - Expert opinion on , 2008 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1517/14712590802494501 Altered peptide ligands of myelin basic protein (MBP87-99) conjugated to reduced mannan modulate immune responses in mice M Katsara, E Yuriev , PA Ramsland , T Tselios - , 2009 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2009.03137.x New routes and opportunities for modular construction of particulate vaccines: stick, click, and glue KD Brune , M Howarth - Frontiers in immunology, 2018 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01432/full Combined triggering of dendritic cell receptors results in synergistic activation and potent cytotoxic immunity JW Wells , CJ Cowled , F Farzaneh - The Journal of , 2008 - journals.aai.orghttps://journals.aai.org/jimmunol/article/181/5/3422/80729 Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice JM Curry, DM Besmer, TK Erick , N Steuerwald - PLoS , 2019 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0224309 Peptide-induced rescue of serologic epitopes on class I MHC molecules. JC Solheim, BM Carreno, NB Myers - (Baltimore, Md.: 1950 , 1995 - journals.aai.orghttps://journals.aai.org/jimmunol/article-abstract/154/3/1188/5920 The major histocompatibility complex JB Lyczak - Immunology, infection, and immunity, 2004 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1128/9781555816148.ch11 Dynamic allostery controls the peptide sensitivity of the Ly49C natural killer receptor J Ma , CM Ayres, LM Hellman, JR Devlin - Journal of Biological , 2021 - ASBMBhttps://www.jbc.org/article/S0021-9258(21)00475-0/abstract Interaction among human leucocyte antigen-peptide-T cell receptor complexes in cow's milk allergy: the significance of human leucocyte antigen and T cell receptor H Sakaguchi, R Inoue, H Kaneko - Clinical & , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1046/j.1365-2222.2002.01370.x Dramatic influence of Vbeta gene polymorphism on an antigen-specific CD8+ T cell response in vivo H Bour, O Michielin, P Bousso, JC Cerottini - The Journal of , 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/162/8/4647/69441 Progression of Pancreatic Adenocarcinoma Is G De Petris , JMB Subramani, T Million Arefayene - J Immunol, 2009 - academia.eduhttps://www.academia.edu/download/42248714/216.pdf Different T Cell Receptor Signals Determine CD8+ Memory Versus Effector Development E Teixeiro , MA Daniels , SE Hamilton , AG Schrum - science, 2009 - science.orghttps://www.science.org/doi/abs/10.1126/science.1163612 Naive T-cell receptor transgenic T cells help memory B cells produce antibody D Duffy , CP Yang, A Heath, P Garside, EB Bell - Immunology, 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2567.2006.02446.x Altered peptide ligand-mediated TCR antagonism can be modulated by a change in a single amino acid residue within the CDR3beta of an MHC class I-restricted TCR AM Kalergis , SG Nathenson - The Journal of Immunology, 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/165/1/280/33371

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 955.09 g/mol
• Formule: C₄₄H₆₆N₁₂O₁₂